Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Not Applicable
1 (33.3%)Evaluation of CYT-108, a Recombinant Protease Inhibitor, for Treatment of Mild to Moderate Primary Osteoarthritis of the Knee
Phase 1
Not yet recruiting
- Conditions
- OsteoarthritisOsteoarthritis, Knee
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Cytonics Corporation
- Target Recruit Count
- 22
- Registration Number
- NCT06263270
- Locations
- 🇦🇺
Emeritus Research, Camberwell, Victoria, Australia
APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee
Phase 1
- Conditions
- OsteoarthritisPain
- First Posted Date
- 2014-08-06
- Last Posted Date
- 2015-08-21
- Lead Sponsor
- Cytonics Corporation
- Target Recruit Count
- 300
- Registration Number
- NCT02210468
- Locations
- 🇺🇸
IRC Clinical, Townsend, Maryland, United States
Safety and Efficacy Study of APIC-PRP in Non-healing Diabetic Foot Ulcers
Not Applicable
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2014-08-06
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- Cytonics Corporation
- Target Recruit Count
- 274
- Registration Number
- NCT02209662
News
No news found